NCT07513116

Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: M.D. Anderson Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To learn whether an eating pattern called intermittent fasting (IF) is tolerable and feasible for individuals at high risk of pancreatic cancer and whether IF is associated with changes in biological markers, including metabolic, inflammatory, microbiome, and imaging-related markers.

Detailed description

Primary Objectives • To assess the tolerability and feasibility of Intermittent fasting (IF) in participants at high risk for pancreatic cancer. Secondary Objectives * To assess changes in oral and gut microbiome after IF. * To assess changes in metabolomic markers after IF. * To assess changes in inflammatory markers after IF.

Conditions

• Evaluating
• Intermittent Fasting
• Pancreatic Cancer

Interventions

Type	Name	Description
OTHER	intermittent fasting	They will fast for 16 consecutive hours each day and have an 8-hour window for eating.

Timeline

• Start date: 2026-09-17
• Primary completion: 2027-03-30
• Completion: 2029-03-30
• First posted: 2026-04-06
• Last updated: 2026-04-14

Locations

1 site across 1 country: United States